Exact Sciences (EXAS) News Today $53.52 -0.49 (-0.91%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$53.48 -0.05 (-0.08%) As of 06/13/2025 07:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock EXAS Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Avanza Fonder AB Reduces Position in Exact Sciences Co. (NASDAQ:EXAS)Avanza Fonder AB reduced its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 30.6% during the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 13,535 shares of the medical research company's stock after selling 5,977 shares during the period.June 13 at 4:21 AM | marketbeat.comPallas Capital Advisors LLC Takes $368,000 Position in Exact Sciences Co. (NASDAQ:EXAS)Pallas Capital Advisors LLC acquired a new stake in Exact Sciences Co. (NASDAQ:EXAS - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 8,509 shares of the medical research company's stocJune 13 at 3:54 AM | marketbeat.comEXACT Sciences (EXAS) Shares Cross Above 200 DMAJune 13 at 12:12 AM | nasdaq.comHarbor Capital Advisors Inc. Has $2.14 Million Holdings in Exact Sciences Co. (NASDAQ:EXAS)Harbor Capital Advisors Inc. trimmed its holdings in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 48.5% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 49,372 shares of the medical research company's stock after selling 46June 12 at 4:51 AM | marketbeat.comMerit Financial Group LLC Acquires 4,609 Shares of Exact Sciences Co. (NASDAQ:EXAS)Merit Financial Group LLC grew its holdings in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 110.0% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 8,799 shares of the medical research company's stock after acquiring an additional 4June 12 at 3:54 AM | marketbeat.comExact Sciences Co. (NASDAQ:EXAS) Stock Position Increased by Thompson Investment Management Inc.Thompson Investment Management Inc. increased its stake in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 4.2% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 251,955 shares of the medical research company's stock after purchasingJune 11 at 9:02 AM | marketbeat.comExact Sciences Co. (NASDAQ:EXAS) Receives $70.90 Average Target Price from AnalystsJune 10, 2025 | americanbankingnews.comExact Sciences Co. (NASDAQ:EXAS) Stock Position Increased by GAMMA Investing LLCGAMMA Investing LLC boosted its position in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 4,899.4% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 183,679 shares of the medical research company's stock afteJune 9, 2025 | marketbeat.comExact Sciences Co. (NASDAQ:EXAS) Receives Average Recommendation of "Moderate Buy" from BrokeragesExact Sciences Co. (NASDAQ:EXAS - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the twenty-two analysts that are covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a hold recommendation, nineteen have given a buy recommendJune 7, 2025 | marketbeat.comCalifornia State Teachers Retirement System Has $16.15 Million Stock Holdings in Exact Sciences Co. (NASDAQ:EXAS)California State Teachers Retirement System decreased its stake in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 2.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 287,410 shares of the medical research comJune 1, 2025 | marketbeat.comUniversal Beteiligungs und Servicegesellschaft mbH Purchases New Stake in Exact Sciences Co. (NASDAQ:EXAS)Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in Exact Sciences Co. (NASDAQ:EXAS - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 159,271 shares of the medical researchJune 1, 2025 | marketbeat.comLansforsakringar Fondforvaltning AB publ Buys New Position in Exact Sciences Co. (NASDAQ:EXAS)Lansforsakringar Fondforvaltning AB publ purchased a new stake in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 67,042 shares of the medical reMay 30, 2025 | marketbeat.comGTS Securities LLC Reduces Stock Position in Exact Sciences Co. (NASDAQ:EXAS)GTS Securities LLC reduced its stake in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 65.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,398 shares of the medical research company's stock after selling 12May 30, 2025 | marketbeat.comExact Sciences Co. (NASDAQ:EXAS) Shares Sold by Tidal Investments LLCTidal Investments LLC lessened its stake in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 63.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,614 shares of the medical research company's sMay 29, 2025 | marketbeat.comExact Sciences Announces Expanded Clinical Validation of the Oncodetect™ Test and Molecular Residual Disease Innovation RoadmapMay 28, 2025 | businesswire.comExact Sciences Co. (NASDAQ:EXAS) Shares Acquired by Polar Asset Management Partners Inc.Polar Asset Management Partners Inc. grew its holdings in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 20.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 81,997 shares of the medical research company's stock afterMay 28, 2025 | marketbeat.comExact Sciences to Participate in June Investor ConferenceMay 27, 2025 | businesswire.comMackenzie Financial Corp Boosts Stake in Exact Sciences Co. (NASDAQ:EXAS)Mackenzie Financial Corp lifted its holdings in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 107.7% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,919,325 shares of the medical research company's stock after buMay 27, 2025 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 81,774 Shares of Exact Sciences Co. (NASDAQ:EXAS)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 6.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owMay 27, 2025 | marketbeat.comExact Sciences Co. (NASDAQ:EXAS) Shares Purchased by Quantinno Capital Management LPQuantinno Capital Management LP increased its position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 205.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 9,991 shares of the medical research coMay 27, 2025 | marketbeat.comBRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Raises Stock Holdings in Exact Sciences Co. (NASDAQ:EXAS)BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp lifted its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 115.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 236,617 shares ofMay 25, 2025 | marketbeat.comWoodline Partners LP Sells 59,467 Shares of Exact Sciences Co. (NASDAQ:EXAS)Woodline Partners LP trimmed its stake in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 15.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 331,988 shares of the medical research company's stock afMay 24, 2025 | marketbeat.comExact Sciences Highlights Innovations in Early Cancer Detection and Precision Oncology at ASCO 2025May 22, 2025 | businesswire.comSpyglass Capital Management LLC Has $86.50 Million Stock Holdings in Exact Sciences Co. (NASDAQ:EXAS)Spyglass Capital Management LLC raised its position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 10.2% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,539,436 shares of the medical research company's stMay 21, 2025 | marketbeat.com18,250 Shares in Exact Sciences Co. (NASDAQ:EXAS) Bought by Triglav Skladi D.O.O.Triglav Skladi D.O.O. acquired a new position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 18,250 shares of the medical research company's stoMay 21, 2025 | marketbeat.comComerica Bank Lowers Position in Exact Sciences Co. (NASDAQ:EXAS)Comerica Bank lessened its stake in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 75.2% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 1,803 shares of the medical research company's stock after selling 5,454 shares during the quarter. Comerica Bank's holdinMay 21, 2025 | marketbeat.comExact Sciences Corporation (EXAS) Slid on Fear of CompetitionMay 20, 2025 | insidermonkey.comTema Etfs LLC Acquires New Position in Exact Sciences Co. (NASDAQ:EXAS)Tema Etfs LLC purchased a new position in Exact Sciences Co. (NASDAQ:EXAS - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 15,008 shares of the medical research company's stock, valued at approximatelyMay 20, 2025 | marketbeat.comRafferty Asset Management LLC Trims Holdings in Exact Sciences Co. (NASDAQ:EXAS)Rafferty Asset Management LLC lessened its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 17.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 212,536 shares of the medical reseMay 19, 2025 | marketbeat.comPolar Asset Management Partners Inc. Has $4.61 Million Position in Exact Sciences Co. (NASDAQ:EXAS)Polar Asset Management Partners Inc. raised its position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 20.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 81,997 shares of the medical resMay 18, 2025 | marketbeat.comPolar Capital Holdings Plc Acquires Shares of 245,402 Exact Sciences Co. (NASDAQ:EXAS)Polar Capital Holdings Plc purchased a new position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 245,402 shares of the medical research company's stock, valued at approMay 18, 2025 | marketbeat.comCetera Investment Advisers Sells 9,312 Shares of Exact Sciences Co. (NASDAQ:EXAS)Cetera Investment Advisers trimmed its stake in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 10.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 82,637 shares of the medical researcMay 17, 2025 | marketbeat.comPiper Sandler Sticks to Their Buy Rating for Exact Sciences (EXAS)May 17, 2025 | theglobeandmail.comEXAS Q1 Earnings Call: Outperformance Driven by Commercial Execution, New Products, and Margin ExpansionMay 16, 2025 | finance.yahoo.comMeridiem Capital Partners LP Takes Position in Exact Sciences Co. (NASDAQ:EXAS)Meridiem Capital Partners LP purchased a new stake in Exact Sciences Co. (NASDAQ:EXAS - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 202,139 shares of the medical research company's stock, valued at approximately $11,35May 15, 2025 | marketbeat.comGotham Asset Management LLC Reduces Position in Exact Sciences Co. (NASDAQ:EXAS)Gotham Asset Management LLC trimmed its holdings in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 7.6% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 150,120 shares of the medical research company's stock after selling 12,302 shares durinMay 15, 2025 | marketbeat.comExact Sciences Co. (NASDAQ:EXAS) Receives Consensus Rating of "Moderate Buy" from AnalystsShares of Exact Sciences Co. (NASDAQ:EXAS - Get Free Report) have been given an average recommendation of "Moderate Buy" by the twenty-two analysts that are currently covering the company, MarketBeat.com reports. Two analysts have rated the stock with a hold rating, nineteen have issued a buy ratiMay 15, 2025 | marketbeat.comIntegral Health Asset Management LLC Acquires 70,000 Shares of Exact Sciences Co. (NASDAQ:EXAS)Integral Health Asset Management LLC boosted its holdings in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 87.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 150,000 shares of the medical researchMay 14, 2025 | marketbeat.com2 Brilliant Stocks to Buy With $200 and Hold for 5 YearsMay 14, 2025 | fool.comIron Triangle Partners LP Buys 200,129 Shares of Exact Sciences Co. (NASDAQ:EXAS)Iron Triangle Partners LP grew its stake in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 50.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 600,000 shares of the medical research compaMay 13, 2025 | marketbeat.comExact Sciences Earns 2025 Great Place To Work® Certification™May 12, 2025 | businesswire.comExact Sciences Co. (NASDAQ:EXAS) Shares Purchased by Granahan Investment Management LLCGranahan Investment Management LLC grew its stake in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 8.2% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 444,064 shares of the medical research company's stock after acquiring an additional 33,823 sMay 12, 2025 | marketbeat.comEnsign Peak Advisors Inc Increases Holdings in Exact Sciences Co. (NASDAQ:EXAS)Ensign Peak Advisors Inc increased its stake in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 7.3% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 1,288,876 shares of the medical research company's stock after purchasing aMay 12, 2025 | marketbeat.comFrontier Capital Management Co. LLC Cuts Holdings in Exact Sciences Co. (NASDAQ:EXAS)Frontier Capital Management Co. LLC reduced its position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 61.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 225,799 shareMay 12, 2025 | marketbeat.comBokf Na Reduces Stake in Exact Sciences Co. (NASDAQ:EXAS)Bokf Na lowered its stake in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 35.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 19,481 shares of the medical research company's stock after sellingMay 11, 2025 | marketbeat.comSchonfeld Strategic Advisors LLC Acquires 17,231 Shares of Exact Sciences Co. (NASDAQ:EXAS)Schonfeld Strategic Advisors LLC increased its stake in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 384.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 21,708 shares of the medical research company'sMay 10, 2025 | marketbeat.comBaird Financial Group Inc. Grows Holdings in Exact Sciences Co. (NASDAQ:EXAS)Baird Financial Group Inc. raised its stake in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 2.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 335,980 shares of the medical research company's stock after purchasing an adMay 9, 2025 | marketbeat.comNorthern Trust Corp Boosts Stock Holdings in Exact Sciences Co. (NASDAQ:EXAS)Northern Trust Corp boosted its stake in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 30.0% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,147,271 shares of the medical research compaMay 9, 2025 | marketbeat.comBraidwell LP Has $19.84 Million Holdings in Exact Sciences Co. (NASDAQ:EXAS)Braidwell LP raised its position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 23.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 353,000 shares of the medical research compMay 8, 2025 | marketbeat.comAmeriprise Financial Inc. Reduces Holdings in Exact Sciences Co. (NASDAQ:EXAS)Ameriprise Financial Inc. reduced its position in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 7.0% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 4,208,039 shares of the medical research company's stock after selling 317,395 shares during the pMay 8, 2025 | marketbeat.com Get Exact Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EXAS and its competitors with MarketBeat's FREE daily newsletter. Email Address EXAS Media Mentions By Week EXAS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EXAS News Sentiment▼1.380.87▲Average Medical News Sentiment EXAS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EXAS Articles This Week▼1011▲EXAS Articles Average Week Get Exact Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EXAS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Alnylam Pharmaceuticals News Biogen News United Therapeutics News Incyte News Neurocrine Biosciences News Exelixis News BioMarin Pharmaceutical News Repligen News Halozyme Therapeutics News Madrigal Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EXAS) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s worst nightmareThe President’s tour of the Middle East… the deal for Ukraine’s mineral rights… Elon’s strange time in Washing...Porter & Company | SponsoredGet in stocks now - and get out on this dateGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exact Sciences Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Exact Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy EXAS Stock Free EXAS Stock Alerts